Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway in Patients After Knee Arthroplasty

June 30, 2017 updated by: Chang Ho Hwang, Ulsan University Hospital

Multi-Modalities Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway of the Proximal Muscles in Patients After Total Knee Arthroplasty

The aim of this study is to determine the clinical efficacy of gait rehabilitation robot through cortico-spinal-muscular pathway activation of the muscles remotely located from the end-effecter in patients after total knee arthroplasty.

Study Overview

Status

Completed

Detailed Description

pre-interventional evaluation; within 1 day of intervention start primary end point; 3 days after intervention start secondary end point; 5 days after intervention start

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients after Unilateral Total Knee Arthroplasty

Exclusion Criteria:

  • brain disease, spinal cord injury, peripheral neuropathy, myopathy
  • Inability to ambulate fully due to muscukoskeletal disorders
  • MMSE<23
  • history of arthroplasty surgery on either of legs
  • Cardiac pacemaker
  • Refusal of participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Morning walk
Rehabilitation using end-effector type gait robot for 5days.
gait training with Morning walk three times during 5 minutes with 5 minute break a day over 5 weekdays
Other Names:
  • end-effector type robot
Active Comparator: Ground Walker
Rehabilitation using walker for 5days.
gait training with ground walker until corresponding 200 steps during 5 minutes with 5 minute break a day over 5 weekdays

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Isometric muscle strength
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
peak torque (Nm/㎡), Maximal ratio of torque development (RTD) (degree/sec)
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Cortico-motor Excitability
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
maximum & mean amplitude of peak to peak MEP (mV and mV), amplitude of peak to peak MEP/maximum M-wave (mV/mV)
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
Change of Spinal Motor-neuron Excitability
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
Peak to peak Max. H-reflex (mV/mV), Peak to peak Max. H-wave/Max. M-reflex (mV/mV*㎡)
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
Change of Cross-sectional area and volume of thigh muscle
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
Cross-sectional area (c㎡) and and volume (cm3)
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
Change of Muscle work
Time Frame: 0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)
peak and mean amplitude of CMAP (mV and mV) and mean area & total area of CMAP (c㎡/sec and c㎡/sec)
0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Actual)

May 15, 2017

Study Completion (Actual)

May 15, 2017

Study Registration Dates

First Submitted

November 2, 2016

First Submitted That Met QC Criteria

November 8, 2016

First Posted (Estimate)

November 11, 2016

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 30, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • chhwang6

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty, Replacement, Knee

Clinical Trials on Morning walk

Subscribe